Produced in by the company EBF technology Eireli do Brasil São Paulo, which is managed by its CEO Dr. Héctor Damián Brzostowski, who due to scientific persecution is in scientific and industrial exile in Brazil and currently exports the products to the whole world, the advances Scientists are not reduced to its mere pharmaceutical molecular composition, but also to its method of application. In order to protect it from its good and correct administration to patients, a franchise was created which has clinical safety and therapeutic efficacy methods
On August 14 and 14 years ago, final products were imported to Brazil to avant-garde therapeutic clinics, after more than 9 years of trials and adjustments of technology management and the political disorders of Argentina, the agronomic problem was solved, it was completed the first harvest of 60 hectares, which yielded a total of 36,000 kg of grapes selected for pharmaceutical extraction for phyto-medicinal production as a dietary supplement that will cover its added value thanks to its technology. In August, the second annual harvest began and it was selected as the best medicinal Ferrari Resveratrol company for a dietary supplement in the world, a company that is no longer in Argentina due to its high taxes and union extortion.
Its pharmaceutical molecular structure and registered in the INPI WIPO OMPI registered in 15 countries makes this molecular structure the most important in current scientific discoveries.
Making great strides in science, technology and global innovation.
Produced in by the company EBF technology Eireli do Brasil São Paulo, which is managed by its CEO Dr. Héctor Damián Brzostowski, who due to scientific persecution is in scientific and industrial exile in Brazil and currently exports the products to the whole world, the advances Scientists are not reduced to its mere pharmaceutical molecular composition, but also to its method of application. In order to protect it from its good and correct administration to patients, a franchise was created which has clinical safety and therapeutic efficacy methods.
Seminar given by Dr. Héctor Damián Brzostowski CEO of the company EBF technology Eireli do Brasil são Paulo
Comentarios
Publicar un comentario